Clinical Trial

A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis

Name: A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis — clinical trial record (NCT07765628)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the efficacy of HS-20118 compared with placebo in participants with moderate to severe plaque psoriasis.

Trial Details

NCT Number	NCT07765628
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	Moderate to Severe Plaque Psoriasis
Enrollment	120 participants
Start Date	2026-08-06
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-07-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-14